| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-19 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-13 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |